9-94567343-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_003837.4(FBP2):c.632G>A(p.Ser211Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00587 in 1,614,156 control chromosomes in the GnomAD database, including 49 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0051 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0060 ( 45 hom. )
Consequence
FBP2
NM_003837.4 missense
NM_003837.4 missense
Scores
6
9
4
Clinical Significance
Conservation
PhyloP100: 7.71
Publications
18 publications found
Genes affected
FBP2 (HGNC:3607): (fructose-bisphosphatase 2) This gene encodes a gluconeogenesis regulatory enzyme which catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.07704571).
BP6
Variant 9-94567343-C-T is Benign according to our data. Variant chr9-94567343-C-T is described in ClinVar as [Benign]. Clinvar id is 1301656.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00595 (8703/1461844) while in subpopulation MID AF = 0.018 (104/5768). AF 95% confidence interval is 0.0152. There are 45 homozygotes in GnomAdExome4. There are 4393 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 776 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00511 AC: 777AN: 152194Hom.: 4 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
777
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00473 AC: 1189AN: 251482 AF XY: 0.00528 show subpopulations
GnomAD2 exomes
AF:
AC:
1189
AN:
251482
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00595 AC: 8703AN: 1461844Hom.: 45 Cov.: 32 AF XY: 0.00604 AC XY: 4393AN XY: 727234 show subpopulations
GnomAD4 exome
AF:
AC:
8703
AN:
1461844
Hom.:
Cov.:
32
AF XY:
AC XY:
4393
AN XY:
727234
show subpopulations
African (AFR)
AF:
AC:
41
AN:
33478
American (AMR)
AF:
AC:
185
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
174
AN:
26136
East Asian (EAS)
AF:
AC:
1
AN:
39700
South Asian (SAS)
AF:
AC:
278
AN:
86258
European-Finnish (FIN)
AF:
AC:
96
AN:
53414
Middle Eastern (MID)
AF:
AC:
104
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
7447
AN:
1111972
Other (OTH)
AF:
AC:
377
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
414
827
1241
1654
2068
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00509 AC: 776AN: 152312Hom.: 4 Cov.: 32 AF XY: 0.00467 AC XY: 348AN XY: 74480 show subpopulations
GnomAD4 genome
AF:
AC:
776
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
348
AN XY:
74480
show subpopulations
African (AFR)
AF:
AC:
49
AN:
41562
American (AMR)
AF:
AC:
93
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
28
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
17
AN:
4824
European-Finnish (FIN)
AF:
AC:
14
AN:
10620
Middle Eastern (MID)
AF:
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
AC:
555
AN:
68022
Other (OTH)
AF:
AC:
17
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
41
81
122
162
203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
14
ALSPAC
AF:
AC:
26
ESP6500AA
AF:
AC:
6
ESP6500EA
AF:
AC:
58
ExAC
AF:
AC:
594
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Jan 06, 2020
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.